ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

FDA warns Zimmer over manufacturing of hip devices

October 1, 2012 5:36 pm by | 0 Comments

warning

Oct 1 (Reuters) - Zimmer Holdings Inc said it received a warning letter from the U.S. Food and Drug Administration citing problems with manufacturing and testing processes for artificial hip devices made at the company's Ponce, Puerto Rico, plant.

The warning letter, dated Sept. 19, does not restrict production or shipment of the hip devices, called Trilogy Acetabular Systems, or require withdrawal of any products from the market, Zimmer said in a regulatory filing.

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
UPMC launches $100M data analytics project with Oracle, IBM to unlock “secrets of human health”
Close